4
total announcements
SAIPARENT.NS · 15 min delayed
Sai Parenterals Limited
Sai Parenterals Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended June 30, 2026.
Sai Parenterals Limited
Sai Parenterals Limited has informed the Exchange regarding the outcome of its Board Meeting held on July 06, 2026, where the Board approved the appointment of secretarial auditors, internal auditors, and cost auditors for the company.
Sai Parenterals Limited
Sai Parenterals' Australian subsidiary, Noumed Pharmaceuticals, has renewed its exclusive OTC supply agreement with a leading Australian pharmacy chain for a 7½-year term, valued at AUD 202 million (approximately INR 1300 crores).
Sai Parenterals Limited
Sai Parenterals Limited has informed the Exchange about bagging/receiving of orders/contracts. The company's subsidiary Noumed Pharmaceuticals Pty Limited has entered an OTC medicines supply agreement with Australia's leading pharmacy network valued at AUD 202 Millions (equivalent to INR 1300 crores). The agreement is for a period of 7.5 years with a further option of 3 years extension upon mutual consent.